FindTrial
Sign In

Correlation Of Interleukin-I7A Levels In Blood And Scales With The Severity Of Psoriasis Disease

Correlation of interleukin-17A Levels In Serum And Scales With The Severity Of Psoriasis - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056432
Enrollment
79
Registered
2023-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

FATHER MULLER MEDICAL COLLEGE
Lead Sponsor
Dr Hiloni Tralshawala
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients with a clinical diagnosis of psoriasis. 2)Presence of active psoriatic skin lesions with scales 3).Age above 18 years

Exclusion criteria

Exclusion criteria: Patients who received any systemic treatment like Methotrexate, Cyclosporine, Apremilast and biologicals for psoriasis in recent 1 month

Design outcomes

Primary

MeasureTime frame
This study will help us understand if there is any correlation between levels of IL17A in serum & scales with psoriasis & if it can be used as a biomarker for disease activity which will help in diagnosis and management of the diseaseTimepoint: The study will be conducted over a period of 18 months—

Secondary

MeasureTime frame
This study will help us understand if there is any correlation between the severity of psoriasis & IL17A levels in serum & scales.Timepoint: At baseline—

Countries

India

Contacts

Public ContactDr Hiloni Tralshawala

FATHER MULLER MEDICAL COLEGE

rameshderma@gmail.com9845084224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026